LLY

997.91

-0.17%↓

JNJ

242.08

-0.3%↓

ABBV

228.95

+0.59%↑

NVS

156.15

-3.77%↓

MRK

116.29

-1.63%↓

LLY

997.91

-0.17%↓

JNJ

242.08

-0.3%↓

ABBV

228.95

+0.59%↑

NVS

156.15

-3.77%↓

MRK

116.29

-1.63%↓

LLY

997.91

-0.17%↓

JNJ

242.08

-0.3%↓

ABBV

228.95

+0.59%↑

NVS

156.15

-3.77%↓

MRK

116.29

-1.63%↓

LLY

997.91

-0.17%↓

JNJ

242.08

-0.3%↓

ABBV

228.95

+0.59%↑

NVS

156.15

-3.77%↓

MRK

116.29

-1.63%↓

LLY

997.91

-0.17%↓

JNJ

242.08

-0.3%↓

ABBV

228.95

+0.59%↑

NVS

156.15

-3.77%↓

MRK

116.29

-1.63%↓

Home・Elenco Azioni・Avidity Biosciences Inc

Avidity Biosciences Inc

Chiusa

SettoreSettore sanitario

15.05 4.51

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

15.05

Massimo

15.05

Metriche Chiave
By Trading Economics
Entrata	-63M -237M
Vendite	-12M 860K
EPS	-1.27
Margine di Profitto	-27,569.884
Dipendenti	511
EBITDA	-59M -232M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	-0.1% downside

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-9B 2.3B
Apertura precedente	10.54
Chiusura precedente	15.05

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

25.575 / 32.65 Supporto e resistenza

Avidity Biosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 mar 2026, 23:01 UTC

Utili

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5 mar 2026, 21:54 UTC

Utili

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5 mar 2026, 21:35 UTC

I principali Market Mover

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6 mar 2026, 00:00 UTC

Principali Notizie su Eventi

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5 mar 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5 mar 2026, 23:33 UTC

Discorsi di Mercato

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5 mar 2026, 23:27 UTC

Discorsi di Mercato

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5 mar 2026, 22:54 UTC

Discorsi di Mercato

Utili

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5 mar 2026, 22:50 UTC

Discorsi di Mercato

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5 mar 2026, 22:48 UTC

Utili

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5 mar 2026, 22:46 UTC

Utili

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5 mar 2026, 22:44 UTC

Utili

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mar 2026, 21:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

5 mar 2026, 21:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

5 mar 2026, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

5 mar 2026, 21:35 UTC

Utili

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mar 2026, 21:32 UTC

Utili

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mar 2026, 21:26 UTC

Utili

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5 mar 2026, 21:24 UTC

Utili

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5 mar 2026, 21:23 UTC

Utili

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5 mar 2026, 21:22 UTC

Utili

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mar 2026, 21:21 UTC

Utili

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5 mar 2026, 21:21 UTC

Utili

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5 mar 2026, 21:20 UTC

Utili

Costco February Net Sales Were $21.69 B >COST

5 mar 2026, 21:20 UTC

Utili

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mar 2026, 21:20 UTC

Utili

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mar 2026, 21:19 UTC

Utili

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5 mar 2026, 21:18 UTC

Utili

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5 mar 2026, 21:18 UTC

Utili

Costco 2Q Same-Store Sales Up 7.4% >COST

5 mar 2026, 21:15 UTC

Utili

Costco 2Q EPS $4.58 >COST

Confronto tra pari

Modifica del prezzo

Avidity Biosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

-0.1% in calo

Previsioni per 12 mesi

Media 72.75 USD -0.1%

Alto 75 USD

Basso 72 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Avidity Biosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Avidity Biosciences Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

25.575 / 32.65Supporto e resistenza

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Recent bearish events outweigh bullish events.

Notizie finanziarie

Chi Siamo Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.